Cerebellar gliomas in children with NF1: pathology and surgery

被引:0
|
作者
M. Vinchon
Gustavo Soto-Ares
Marie-Madeleine Ruchoux
Patrick Dhellemmes
机构
[1] Department of Pediatric Neurosurgery,
[2] CHRU de Lille,undefined
[3] 59037 Lille Cedex,undefined
[4] France e-mail: m-vinchon@chru-lille.fr Tel.: +33-3-20445455 Fax: +33-3-20445511,undefined
[5] Department of Neuroradiology,undefined
[6] CHRU de Lille,undefined
[7] 59037 Lille Cedex,undefined
[8] France,undefined
[9] Department of Neuropathology,undefined
[10] CHRU de Lille,undefined
[11] 59037 Lille Cedex,undefined
[12] France,undefined
来源
Child's Nervous System | 2000年 / 16卷
关键词
Keywords Neurofibromatosis type 1; Cerebellar neoplasms; Pilocytic astrocytoma; Anaplastic astrocytoma; Ganglioglioma; Tumor growth rate;
D O I
暂无
中图分类号
学科分类号
摘要
Cerebellar gliomas associated with NF1 (CGNF1) are rarely reported in the literature, and they are considered to be malignant in a high proportion of cases. In an attempt to improve the definition of this disease and clarify its management, we reviewed our patients with CGNF1 and compared their tumors with sporadic cerebellar gliomas (SGC). We operated on six children with CGNF1, all but one of whom were asymptomatic. They represented one-tenth of all pediatric cerebellar gliomas, and one third of NF1- associated gliomas seen in our institution. CGNF1 appeared at a later age than SCG. They are seated near the roof of the IV ventricle and are not related to white matter hypersignal hamartomas. Most of these tumors showed radiological progression. They were four pilocytic astrocytomas, one ganglioglioma, and one malignant astrocytoma. One patient had tumor recurrence after 8 years, and the others are still disease free. The overall outcome appeared to be better for GCNF1 than for SCG. On account of the regular growth, uncertain pathology, and good surgical outcome, we advocate systematic resection of these tumors.
引用
收藏
页码:417 / 420
页数:3
相关论文
共 50 条
  • [1] Cerebellar gliomas in children with NF1: pathology and surgery
    Vinchon, M
    Soto-Ares, G
    Ruchoux, MM
    Dhellemmes, P
    CHILDS NERVOUS SYSTEM, 2000, 16 (07) : 417 - 420
  • [2] MRI OF OPTIC PATHWAY GLIOMAS IN CHILDREN WITH AND WITHOUT NF1
    Warmuth-Metz, M.
    Leykamm, S.
    Bison, B.
    Thieme, B.
    Mirow, C.
    Gnekow, A. K.
    NEURO-ONCOLOGY, 2010, 12 (06) : II94 - II94
  • [3] Prevalence and predicting factors of endocrine dysfunction in children with NF1 and optic gliomas
    Santoro, Claudia
    Perrotta, Silverio
    Scilipoti, Martina
    Cirillo, Mario
    Quaglietta, Lucia
    Cinalli, Giuseppe
    Cioffi, Daniela
    Di Iorgi, Natascia
    Gallizia, Annalisa
    Maghnie, Mohamad
    Parpagnoli, Maria
    Messa, Federica
    Vannelli, Silvia
    De Sanctis, Luisa
    Marzuillo, Pierluigi
    del Giudice, Emanuele Miraglia
    Grandone, Anna
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 100 - 101
  • [4] CARBOPLATIN AND VINCRISTINE CHEMOTHERAPY FOR NF1 CHILDREN WITH PROGRESSIVE OPTIC PATHWAY GLIOMAS
    Allen, Jeffrey C.
    Mathew, Jeena
    Hartnett, Erin
    Karajannis, Matthias
    Gardner, Sharon
    Ater, Joan
    NEURO-ONCOLOGY, 2009, 11 (05) : 637 - 637
  • [5] Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference
    Packer, Roger J.
    Iavarone, Antonio
    Jones, David T. W.
    Blakeley, Jaishri O.
    Bouffet, Eric
    Fisher, Michael J.
    Hwang, Eugene
    Hawkins, Cynthia
    Kilburn, Lindsay
    MacDonald, Tobey
    Pfister, Stefan M.
    Rood, Brian
    Rodriguez, Fausto J.
    Tabori, Uri
    Ramaswamy, Vijay
    Zhu, Yuan
    Fangusaro, Jason
    Johnston, Stephen A.
    Gutmann, David H.
    NEURO-ONCOLOGY, 2020, 22 (06) : 773 - 784
  • [6] ADULT BRAINSTEM GLIOMAS IN NEUROFIBROMATOSIS TYPE 1 (NF1)
    Guillamo, J.
    Wang, A.
    Ducray, F.
    Barbarot, S.
    Chinot, O.
    Frappaz, D.
    Bauchet, L.
    Wolkenstein, P.
    Laigle-Donadey, F.
    NEURO-ONCOLOGY, 2019, 21 : 74 - 74
  • [7] Cerebellar Radiological Abnormalities in Children with Neurofibromatosis Type 1 (NF1): A Natural History Study
    Salman, M.
    Hossain, S.
    Gorun, S.
    Alqublan, L.
    Bunge, M.
    Rozovsky, K.
    ANNALS OF NEUROLOGY, 2018, 84 : S387 - S387
  • [8] The handwriting performance of children with NF1
    Gilboa, Yafit
    Josman, Naomi
    Fattal-Valevski, Aviva
    Toledano-Alhadef, Hagit
    Rosenblum, Sara
    RESEARCH IN DEVELOPMENTAL DISABILITIES, 2010, 31 (04) : 929 - 935
  • [9] Is There an Independent Role of TERT and NF1 High Grade Gliomas?
    Razis, Evangelia
    Kotoula, Vassiliki
    Koliou, Georgia-Angeliki
    Papadopoulou, Kyriaki
    Vrettou, Eleni
    Giannoulatou, Eleni
    Tikas, Ioannis
    Labropoulos, Stefanos, V
    Rigakos, Georgios
    Papaemmanoyil, Styliani
    Romanidou, Ourania
    Bourkoula, Eugenia
    Nomikos, Panagiotis
    Iliadis, Georgios
    Nasioulas, George
    Polyzoidis, Konstantinos
    Fountzilas, George
    Selviaridis, Panagiotis
    TRANSLATIONAL ONCOLOGY, 2020, 13 (02): : 346 - 354
  • [10] THREE YEAR VISUAL OUTCOMES AFTER CHEMOTHERAPY FOR NF1 OPTIC PATHWAY GLIOMAS IN CHILDREN
    Fisher, Michael J.
    Ullrich, Nicole J.
    Ferner, Rosalie E.
    Gutmann, David H.
    Listernick, Robert
    Packer, Roger J.
    Tabori, Uri
    Hoffman, Robert O.
    Ardern-Holmes, Simone L.
    Hummel, Trent R.
    Hargrave, Darren R.
    Charrow, Joel
    Loguidice, Michael
    Balcer, Laura J.
    Liu, Grant T.
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1074 - 1075